SYRE FY 2017 Earnings — Spyre Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SYRESpyre Therapeutics, Inc.

$3B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+12.5% YoY

Gross Profit

$00.0% margin

Operating Income

-$28M-531.7% margin

Net Income

-$27M-523.3% margin

EPS (Diluted)

$-45.01

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$25M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$56M

Total Liabilities

$6M

Stockholders' Equity

$50M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$5M	+12.5%
Gross Profit	$0	$0	—
Operating Income	-$28M	-$22M	-26.3%
Net Income	-$27M	-$22M	-25.5%